Pharmacotherapy considerations for morning symptoms in chronic obstructive pulmonary disease

Expert Opin Pharmacother. 2022 Aug;23(12):1359-1362. doi: 10.1080/14656566.2022.2116274. Epub 2022 Aug 24.

Authors

Clarus Leung¹, Don D Sin²

Affiliations

¹ Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
² Department of Medicine, University of British Columbia & Director, Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.

PMID: 35986503
DOI: 10.1080/14656566.2022.2116274

No abstract available

Keywords: Chronic obstructive pulmonary disease; circadian rhythm; long-acting bronchodilators.

Publication types

Editorial

MeSH terms

Administration, Inhalation
Bronchodilator Agents
Humans
Pulmonary Disease, Chronic Obstructive*

Substances

Bronchodilator Agents